+33 pts


InteliSwab Upside Drives 2Q; Govt. to Keep Buying For Now, But LT Durability Still Unknown

We maintain our Market Perform rating on shares of OraSure after the company posted a strong InteliSwab-driven beat (InteliSwab +$19M vs. RJe) for 2Q but...

By RayHold on Aug. 11, 2022, 9:45 a.m.
Tagged topics: diagnostics
Views: 11, Votes: 4, Responses: 0, Attachments: 1

Please login to view full post with attachments.

Signup/Login to collect points for voting and responding. Points can be used to unlock content.

Similar posts others by others on these stocks